New Electrocardiogram Technology

By HospiMedica staff writers
Posted on 28 Feb 2005
A new electrocardiogram designed to be a highly accurate diagnostic tool is based on technology licensed from the U.S. National Aeronautics and Space Administration (NASA, Washington, DC, USA).

The high frequency QRS (HFQRS) electrocardiogram, comprised of sophisticated software algorithms is being co-developed by CardioSoft (Houston, TX, USA) and researchers at NASA's Johnson Space Center (also in Houston). The software algorithms measure, in real-time, signals present in the QRS complex, or heart-muscle depolarization phase, of the electrocardiogram. These signals are unrecognized by current ECG methods.

"Our development efforts will enable a highly accurate, five-minute resting test that can be readily obtained whenever and wherever conventional ECG is performed,” stated Saeed Moradi, co-founder of CardioSoft. "Improved accuracy of HFQRS compared with conventional ECG has already been demonstrated in over 800 patients studied to date by leading researchers.”

CardioSoft is a pioneering medical technology company that is developing products to improve the lives of people at risk for heart disease. The company was formed in 2004 by a team of doctors, engineers, and high-tech medical entrepreneurs.

"We are very excited about commercializing this innovative technology, because it can have a real impact on the diagnosis and management of a major cause of morbidity and mortality in modern society,” added Saeed Moradi.




Related Links:
CardioSoft

Latest Critical Care News